News
Resources
Blog
Sites
New poll shows Americans reject Medicare “negotiation” once they learn more about the policy
By Cynthia Hicks | October 15, 2021
As the debate in Washington around drug pricing proposals continues to intensify, a new Ipsos/PhRMA poll shows Medicare “negotiation” is not nearly as popular as some might suggest. Survey...
Read More
New report shows 3 in 10 Americans that have insurance still face a financial barrier to care
By Katie Koziara | October 7, 2021
Today, we released the results in the first report in a series on patient experiences with the health care system. The report, titled “Barriers to Health Care Access in the Patient Experience,”...
Read More
PhRMA releases 2021 industry profile
By Gabby Migliara | September 20, 2021
Today, PhRMA released its 2021 Biopharmaceutical Industry Profile, a resource that highlights the latest from the industry on innovation, access and affordability. The Profile has told the story...
Read More
By
Health care costs and affordability remain a major challenge for most Americans, even among those with insurance. According to a March Gallup poll, nearly one-in-five (18%) U.S. adults report that...
Read More
H.R. 3 threatens access to medicines, future innovation and American jobs
By Gabby Migliara | May 4, 2021
In the last election, voters made clear that they want quality, affordable health coverage that works when they need it and lower out-of-pocket costs for medicines. And we can achieve those goals,...
Read More
To continue to drive the innovation economy and exports, American biopharmaceutical sector depends on fair trade agreements
By Jay Taylor | May 10, 2018
May is World Trade Month, when we celebrate the many American companies exporting products around the world, and growing opportunities here in the U.S.
Read More
Video: PhRMA CEO discusses biopharmaceutical supply chain at POLITICO event
By Holly Campbell | May 4, 2018
Yesterday, PhRMA president and CEO Stephen J. Ubl spoke at POLITICO’s “Deconstructing the Prescription Drug Supply Chain” event, discussing the incredible new era of medicine, medicine spending...
Read More
Guest Post: Policy conditions make or break leaders in biopharmaceutical innovation: Preliminary results from the 2017 BCI Survey
By Guest Contributor | July 24, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
A critical opportunity to prevent prescription drug abuse
By Anne McDonald Pritchett, PhD | June 2, 2017
U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb recently cited addressing the opioid crisis as his highest priority. As someone who has spent the bulk of my career focused on...
Read More
340B Spotlight: 340B hospitals continue to benefit from consolidation at expense of patients
By Rebecca Davison | April 27, 2017
As we’ve noted before, incentives to profit under the 340B program are leading to an uneven playing field for providers and may be shifting care to more expensive and less convenient settings in...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
